Suppr超能文献

评估和管理与局部使用苯佐卡因相关的获得性高铁血红蛋白血症。

Evaluation and management of acquired methemoglobinemia associated with topical benzocaine use.

机构信息

Division of Cardiovascular Medicine, Department of Medicine, University of Toledo Medical Center, 3000 Arlington Avenue, Toledo, OH, 43614, USA.

出版信息

Am J Cardiovasc Drugs. 2013 Oct;13(5):325-30. doi: 10.1007/s40256-013-0027-2.

Abstract

Benzocaine is a widely used topical oropharyngeal anesthetic and has been reported to cause methemoglobinemia. We discuss benzocaine-induced methemoglobinemia and review the causes, presentation, and management of this serious complication. Treatment with methylene blue will result in reversal of methemoglobinemia and clinical recovery in most cases but needs to be used at appropriate doses in carefully selected individuals. Physicians who perform procedures involving the application of benzocaine for topical anesthesia need to rapidly identify and treat methemoglobinemia to avoid significant associated morbidity and mortality.

摘要

苯佐卡因是一种广泛应用于局部口腔的麻醉剂,据报道可引起高铁血红蛋白血症。我们讨论了苯佐卡因引起的高铁血红蛋白血症,并回顾了这种严重并发症的病因、表现和处理方法。亚甲蓝治疗可使高铁血红蛋白血症逆转并使大多数患者的临床情况恢复,但需要在仔细选择的个体中使用适当剂量。行涉及苯佐卡因局部麻醉应用的操作的医生需要快速识别和治疗高铁血红蛋白血症,以避免严重的相关发病率和死亡率。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验